cholesteryl ester transfer protein inhibitors (Lilly)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecholesteryl ester transfer protein inhibitors (Lilly)
Drug Alias NameCETP inhibitors (Lilly)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesteryl ester transfer protein inhibitors
TargetsCholesteryl ester transfer protein
Therapy Area/IndicationsHyperlipidemiasAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A